Physician
Rocky Mountain Pathology Consultants, PC
Rocky Mountain Pathology Consultants, PC was paid $648K by Medicaid between Jan 2018 and Jul 2024, across 98 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 10% of everything it billed.
33Billing provider infoROCKY MOUNTAIN PATHOLOGY CONSULTANTS, PC
PARKER, CO 80134
PARKER, CO 80134
33aNPI1972904415assigned 09/15/2014
33bProvider typeClinical Pathology Physician
28Total paid$648K
24GClaims58,117
24DCodes billed98
24AFirst – last monthJan 2018 – Jul 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,966 | $207K | |
| 2019 | 16,370 | $156K | |
| 2020 | 7,259 | $101K | |
| 2021 | 7,269 | $90K | |
| 2022 | 3,330 | $49K | |
| 2023 | 1,216 | $31K | |
| 2024incomplete | 707 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 10% | 2,218 | 2,034 | $66K |
| 80053 | Comprehensive metabolic panel | 8.8% | 5,859 | 4,964 | $57K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 8.7% | 1,801 | 1,616 | $56K |
| 84443 | Thyroid stimulating hormone (TSH) | 8.7% | 3,968 | 3,308 | $56K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.0% | 7,339 | 5,313 | $46K |
| 80061 | Lipid panel | 6.6% | 3,304 | 3,015 | $43K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.2% | 699 | 607 | $34K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.2% | 3,100 | 2,749 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.0% | 517 | 230 | $26K |
| 82607 | 3.8% | 1,589 | 1,471 | $24K | |
| 88142 | 3.7% | 1,501 | 1,371 | $24K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.2% | 1,033 | 927 | $21K |
86 more codes
| 80050 | General health panel | 3.2% | 513 | $20K |
| 84481 | 2.5% | 1,239 | $16K | |
| 84439 | 2.1% | 1,895 | $14K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.3% | 57 | $9K |
| 84403 | 1.2% | 601 | $8K | |
| 86141 | 1.1% | 1,040 | $7K | |
| 82728 | 1.1% | 490 | $7K | |
| 82746 | <1% | 414 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 164 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 258 | $6K |
| 86003 | <1% | 61 | $5K | |
| 83550 | <1% | 643 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 181 | $4K |
| 87481 | <1% | 30 | $4K | |
| 84270 | <1% | 417 | $4K | |
| 84153 | <1% | 398 | $4K | |
| 83540 | <1% | 614 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 322 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,991 | $3K |
| 85651 | <1% | 740 | $2K | |
| 84550 | <1% | 772 | $2K | |
| 83090 | <1% | 222 | $2K | |
| 86140 | <1% | 321 | $2K | |
| 83525 | <1% | 261 | $1K | |
| 87511 | <1% | 42 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 231 | $1K |
| 87535 | <1% | 115 | $1K | |
| 85610 | <1% | 347 | $1K | |
| 84144 | <1% | 141 | $1K | |
| 87088 | <1% | 211 | $1K | |
| 83690 | <1% | 345 | $1K | |
| 81003 | <1% | 561 | $1K | |
| 84402 | <1% | 468 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 170 | $992.08 |
| 83001 | <1% | 89 | $957.45 | |
| 83735 | <1% | 332 | $948.02 | |
| 86803 | <1% | 88 | $941.97 | |
| 83002 | <1% | 70 | $807.18 | |
| 84100 | <1% | 334 | $665.68 | |
| 84436 | <1% | 167 | $616.76 | |
| 84480 | <1% | 150 | $580.94 | |
| 88141 | <1% | 33 | $534.47 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $421.08 |
| 82670 | <1% | 24 | $406.01 | |
| 87590 | <1% | 56 | $363.30 | |
| 82570 | <1% | 77 | $327.36 | |
| 86431 | <1% | 109 | $309.12 | |
| 86665 | <1% | 48 | $295.68 | |
| 82040 | <1% | 62 | $285.45 | |
| 82565 | <1% | 121 | $285.12 | |
| 81015 | <1% | 272 | $284.92 | |
| 82043 | <1% | 48 | $283.42 | |
| 84450 | <1% | 58 | $283.30 | |
| 84075 | <1% | 57 | $274.99 | |
| 82310 | <1% | 55 | $272.03 | |
| 82247 | <1% | 56 | $264.51 | |
| 86592 | <1% | 89 | $244.64 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 574 | $238.92 |
| 86255 | <1% | 25 | $234.15 | |
| 82947 | <1% | 58 | $226.58 | |
| 82627 | <1% | 20 | $205.38 | |
| 86628 | <1% | 28 | $202.15 | |
| 84155 | <1% | 57 | $196.94 | |
| 83516 | <1% | 16 | $182.76 | |
| 82150 | <1% | 23 | $162.45 | |
| 80164 | <1% | 16 | $160.83 | |
| 82550 | <1% | 40 | $120.54 | |
| 87077 | <1% | 14 | $109.80 | |
| 85730 | <1% | 29 | $102.57 | |
| 87184 | <1% | 31 | $98.12 | |
| 80076 | <1% | 22 | $97.20 | |
| 87102 | <1% | 16 | $76.09 | |
| 86360 | <1% | 39 | $45.96 | |
| 84460 | <1% | 61 | $36.80 | |
| 86357 | <1% | 23 | $24.45 | |
| 86359 | <1% | 32 | $22.98 | |
| 86355 | <1% | 18 | $17.36 | |
| 87205 | <1% | 15 | $16.68 | |
| 84295 | <1% | 104 | $9.57 | |
| 84132 | <1% | 59 | $9.42 | |
| 82465 | <1% | 20 | $8.62 | |
| 83718 | <1% | 19 | $8.11 | |
| 85007 | <1% | 14 | $4.56 | |
| 82374 | <1% | 58 | $4.30 | |
| 84478 | 0% | 18 | $0.00 | |
| 82435 | 0% | 57 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTEWART, MAYA (MANAGER)